Toxicogenomic and bioinformatics platforms to identify key molecular mechanisms of a curcumin-analogue DM-1 toxicity in melanoma cells-Reference-Cited by-同舟云学术

Toxicogenomic and bioinformatics platforms to identify key molecular mechanisms of a curcumin-analogue DM-1 toxicity in melanoma cells

Published:2017-11 Issue: Volume:125 Page:178-187
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Oliveira Érica Aparecida de,Lima Diogenes Saulo de,Cardozo Lucas Esteves,Souza Garcia Ferreira de,de Souza Nayane,Alves-Fernandes Debora Kristina,Faião-Flores Fernanda,Quincoces José Agustín Pablo,Barros Silvia Berlanga de Moraes,Nakaya Helder I.,Monteiro Gisele,Maria-Engler Silvya Stuchi

Funder

PNPD/CAPES and FAPESP

Publisher

Elsevier BV

Subject

Pharmacology

Reference80 articles.

1. Melanoma: from mutations to medicine;Tsao;Genes Dev.,2012

2. From genes to drugs: targeted strategies for melanoma;Flaherty;Nat. Rev. Cancer,2012

3. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial

4. Fibroblast-mediated drug resistance in cancer;Paraiso;Biochem. Pharmacol.,2013

5. BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact;Rizos;Clin. Cancer Res.,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of miRNA‐lncRNA‐mRNA co‐expression network affecting EMT‐ mediated cisplatin resistance in ovarian cancer;Journal of Cellular and Molecular Medicine;2022-07-10

2. Curcumin suppresses cell proliferation and triggers apoptosis in vemurafenib‐resistant melanoma cells by downregulating the EGFR signaling pathway;Environmental Toxicology;2022-01-07

3. TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors;Pharmacological Research;2021-11

4. Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: An update with promising analogues;European Journal of Pharmacology;2021-09

5. Metalloproteinases Suppression Driven by the Curcumin Analog DM-1 Modulates Invasion in BRAF-Resistant Melanomas;Anti-Cancer Agents in Medicinal Chemistry;2020-08-20